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Abstract 
 
Breathing pattern as periodic breathing (PB) in chronic heart failure (CHF) is associated with poor 
prognosis and high mortality risk. This work investigates the signiﬁcance of a number of time domain 
parameters for characterizing respiratory ﬂow cycle morphology in patients with chronic heart failure 
(CHF). Thus, our primary goal is to detect PB pattern and identify patients at higher risk. In addition, 
diﬀerences in respiratory ﬂow cycle morphology between CHF patients (with and without PB) and 
healthy subjects are studied. Diﬀerences between these parameters are assessed by investigating the 
following three classiﬁcation issues: CHF patients with PB vs. with non-periodic breathing (nPB), 
CHF patients (both PB and nPB) vs. healthy subjects, and nPB patients vs. healthy subjects. 26 CHF 
patients (8/18 with PB/nPB) and 35 healthy subjects are studied. The results show that the maximal 
expiratory ﬂow interval is shorter and with lower dispersion in CHF patients than in healthy subjects. 
The ﬂow slopes are much steeper in CHF patients, especially for PB. Both inspiration and expiration 
durations are reduced in CHF patients, mostly for PB. Using the classiﬁcation and regression tree 
technique, the most discriminant parameters are selected. For signals shorter than 1 min, the time 
domain parameters produce better results than the spectral parameters, with accuracies for each 
classiﬁcation of 82/78%, 89/85% and 91/89%, respectively. It is concluded that morphologic analysis 
in the time domain is useful, especially when short signals are analyzed.  
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1. Introduction 
Chronic heart failure (CHF) is a growing epidemic in Western countries with increasing incidence 
and prevalence [5]. Despite important progress in recent decades, mortality remains high for patients 
with CHF. Moreover, established indexes such as New York Heart association (NYHA) functional 
class and the left ventricular ejection fraction (LVEF), associated with the laboratory values and 
medication use do not fully explain the mortality risk of patients with CHF and do not estimate an 
individual’s prognosis [29], [18], [3]. CHF is associated with major abnormalities in the autonomic 
cardiovascular control, characterized by enhanced sympathetic nerve activity and cardiorespiratory 
disorder. 
Breathing disorders are very common in CHF patients, usually manifested as a centrally-driven, 
rhythmic rise and fall in ventilation [26]. This type of breathing pattern, referred to as periodic 
breathing (PB), can be classiﬁed into ventilation with apnea, known as Cheyne–Stokes respiration, 
or without apnea [20], [17]. With a prevalence as high as 70% in CHF patients [27], the PB pattern 
has been established as a powerful predictor of poor prognosis in these patients [7] and increased 
mortality [11], especially in patients with Cheyne–Stokes respiration [30], [4]. 
Various parameters have been suggested for the characterization and identiﬁcation of diﬀerent 
breathing patterns [15], [31], [32], [35]. For example, the sleep-disordered breathing index is 
associated with an accelerated decline in cardiac function and in- creased morbidity and mortality 
[12], [13]. Sympathetic activity was found to increase with faster breathing rates and to decrease with 
higher tidal volumes in CHF patients. Some reports shown that the baroreﬂex sensitivity in CHF 
patients under basal con- ditions was lower than that of healthy subjects [1]. Short-term analysis of 
HRV has independent prognostic value of CHF patients: reduced low-frequency power during 
controlled breathing is a predictor of sudden death [16]. 
Several studies have reported that central sleep apnea is highly prevalent among patients with CHF 
[36], [34]. The continuous positive airway pressure treatment of obstructive sleep apnea in CHF 
patients demonstrated signiﬁcant improvements in cardiac function and left ventricular systolic 
function, and attenuation of sympathetic nerve activity [14], [21]. We have previously characterized 
the respiratory pattern in CHF patients and healthy subjects using spectral parameters computed from 
the enve- lope of the respiratory ﬂow signal [9]. In a subsequent study, we used the correntropy 
function, extracting parameters based on the correntropy spectral density (CSD) to detect 
nonlinearities in the respiratory ﬂow signal [10]. 
The aim of this work is to study the morphology of the respiratory ﬂow cycle in CHF patients with 
PB and non-periodic breathing (nPB). We analyze the evolution of morphology over time using a 
novel template-based technique. In general, diﬀerences in the spectral domain between CHF and 
healthy subjects are related to the modulation of the respiratory signal. The modulation may be 
characterized in the time domain by quantifying morphologic changes in the respiratory cycle, 
potentially oﬀering the advantage of requiring shorter signals for analysis than required for 
computing the correntropy function. 
 
2. Methods 
The study of respiratory ﬂow cycle morphology involves the following processing steps: 
segmentation and time alignment, computation of a respiratory cycle template from which a set of 
time domain parameters are extracted. On the other hand, CSD- based parameters are computed so 
that these results can be compared with those of the morphologic parameters. Finally, statistical 
analysis and respiratory pattern classiﬁcation are performed. 
 
2.1. Dataset 
Respiratory ﬂow signals were recorded from 26 CHF patients (20 males; 65 ± 9 years) and 35 healthy 
volunteers (12 males; 27 ± 7 years) at Santa Creu i Sant Pau Hospital, Barcelona, Spain; see [9] for 
more details of the dataset. The study was approved by the local Ethics Committee. The signals were 
originally recorded at a sampling rate of 250 Hz, for 15 min, but, given that the frequency content of 
interest is below 1 Hz, the signals were decimated to 10 Hz using zero-phase, antialiasing ﬁltering. 
All signals were analyzed visually by an experienced physician. According to clinical criteria, the 
PB patterns were visually identiﬁed by analyzing the waxing and waning of the respiratory ﬂow 
signal. The CHF patients were divided into two groups: 8 patients with PB pattern (7 male; 71  ± 7 
years) and 18 patients with nPB pattern (13 male; 63 ± 9 years). 
Figure 1 illustrates respiratory ﬂow signals with patterns observed in CHF patients (PB and nPB) and 
in a healthy subject. For the entire dataset with 61 subjects, the respiratory rate was found to range 
from 11.5 to 29.0 breaths/min. The characteristics of the CHF patients and healthy subjects, in terms 
of respiratory rate and the duration of inspiratory and expiratory cycles, are shown in Table 1.  
 
Fig. 1 Respiratory ﬂow signals from (a) a CHF-PB patient, (b) a CHF-nPB patient, and (c) a healthy 
subject (n.u. denotes normalized units). 
 
Table 1 Respiratory Rate (Mean ± Standard Deviation) in CHF Patients and Healthy Subjects 
CHF 
PB 
(n = 8) 
nPB 
(n = 18) 
Rf (breaths/min) 22.5 ± 4.3 18.4 ± 2.2 
DI (s) 
0.97 ± 0.20 1.14 ± 0.18 
DE (s) 
1.79 ± 0.38 2.16 ± 0.32 
 CHF Healthy subjects 
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(n = 8) (n = 18) 
Rf (breaths/min) 19.6 ± 3.4 15.5± 3.7 
DI (s) 
1.09 ± 0.20 1.8 ± 0.35 
DE (s) 
2.05 ± 0.38 2.3± 0.64 
Rf : Respiratory rate; DI : Duration of inspiration; DE : Duration of inspiration. 
 
2.2. Segmentation and Time Alignment 
The respiratory ﬂow signal is analyzed using a sliding window of 30-s length (80% overlap); this 
choice was based on the observation that the period length of PB ranges from 25 to 100 s (i.e., 10–
20 cycles) [28]. The alignment method was found to perform particularly well for small ensemble 
sizes. 
The signal is normalized with respect to its largest absolute amplitude, and all cycles within the 
window are extracted using an algorithm that ﬁnds the zero-crossings of the respiratory ﬂow signal. 
The resulting ensemble of successive respiratory cycles is represented by an N × M data matrix X, 
𝑿 =  [𝑋1    𝑋2    ⋯    𝑋𝑀]   ,                            (1) 
where each column Xi  contains N samples of the i:th cycle, and M is the total number of respiratory 
cycles. 
To ensure that the signal ensemble is well-aligned, a novel eigenvalue-based method is employed 
which performs joint alignment of all signals; for more information on the method and its 
performance, see [8]. The method is based on the eigenvalue decomposition of the N x N sample 
correlation matrix as 
?̂?𝒙 =   
1
𝑀
 𝑿𝑿𝑻   .                                 (2) 
Interestingly, the ratio 𝜃 between the largest eigenvalue 1 of ?̂?𝒙 and the sum of the remaining N 
− 1 eigenvalues, i.e., 
𝜃 =   
1
∑ 𝑖
𝑁
𝑖=2
    ,                                 (3) 
can be interpreted as a signal-to-jitter-and-noise ratio [8]. Optimal alignment is obtained by ﬁnding 
those column shifts 𝜃1, ⋯ , 𝜃𝑀 which maximize the ratio 𝜃. This is accomplished by shifting all 
columns symmetrically around their initial positions (corresponding to cycles aligned to the maximal 
inspiration), resulting in a combinatorial optimization problem. 
 
2.3. Respiratory flow cycle template 
A respiratory ﬂow cycle template is calculated from the sliding window by computing the ensemble 
average of time-aligned respiratory ﬂow cycles. The template is then characterized by a set of time 
domain parameters reﬂecting inspiratory and expiratory time intervals, maximal inspiratory and 
expiratory ﬂow values, and down-/upward inspiratory and expiratory slopes, see Table 2 for a list of 
the parameters, and Fig. 2 for graphical representation. 
 
Table 2 Time Domain Parameters Extracted from the Respiratory Flow Cycle Template 
Parameter Description 
DI [s] Inspiration duration 
DE [s] Expiration duration  
M I [n.u.] Maximal inspiratory flow 
M E [n.u.] Maximal expiratory flow 
I I [s] Maximal inspiratory flow interval 
I E [s] Maximal expiratory flow interval  
S I 1 [n.u.] Upward inspiratory slope 
S I 2 [n.u.] Downward inspiratory slope 
S E 1 [n.u.] Downward expiratory slope 
S E 2 [n.u.] Upward expiratory slope 
 
 
 
 
 Fig. 2 Time domain parameters extracted from the respiratory flow cycle template.  
 
 
2.4. Spectral parameters 
We showed that the CSD was particularly well-suited for the characterization of modulated breathing 
patterns [10]. In this study, the same characterization is applied but with signals much shorter than 
the 15 min used in [10]; here, the signal length ranges from 1 to 5 min, incremented in steps of 30 s. 
The CSD can be viewed as a generalization of the conventional power spectral density, but with 
better spectral resolution. The CSD-based parameters are derived from frequency bands centered 
around the peaks corresponding to the respiratory frequency and the modulation frequency, see Table 
3. 
Table 3 Parameters based on the Correntropy Spectral Density 
Parameter Description 
Pm  Power of the modulation frequency band  
Pr  Power of the respiratory frequency band  
R Pm / Pr 
V Correntropy mean 
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 2.5. Data Analysis 
In order to analyze the dynamics of the respiratory ﬂow cycle morphology over different signal 
lengths, the mean and standard deviation of each time domain parameter are computed. Statistical 
analysis is carried out using IBM SPSS software (v19). Diﬀerences between groups are tested by the 
Mann–Whitney U test and a p-value < 0.05 was considered statistically signiﬁcant. The classiﬁcation 
and regression tree technique is used to select the most discriminant parameters and classify, in a 
binary way, the diﬀerent breathing patterns using leave-one-out crossvalidation. To allow for 
comparison with previous studies, the same classiﬁcation framework is employed: 1) PB vs. nPB 
patients, 2) CHF patients vs. healthy subjects, and 3) nPB patients vs. healthy subjects. To avoid 
overﬁtting, we followed the ten events per parameter rule and consequently used only one parameter 
for each classiﬁcation [25]. Parameters oﬀering the best discriminatory power are presented in terms 
of accuracy, sensitivity, and speciﬁcity. 
 
3. Results 
3.1. Illustration of the Method 
Examples of respiratory ﬂow signals, respiratory cycle templates, and parameter trends are presented 
in Figs. 3, 4, and 5, for a patient with PB, a patient with nPB, and a healthy subject, respectively. It 
is noted from Fig. 3 that PB periodicity is well reﬂected by the trends of maximal inspiratory (M I ), 
expiratory (M E ) ﬂow value, and duration of expiration (D E ). 
The upward and downward slopes of inspiration and expiration are represented by their respective 
mean values for each of the four groups, i.e., PB, nPB, CHF, and healthy, see Fig. 6. The respiratory 
ﬂow cycle in CHF patients is compressed, especially for those with PB who exhibit the steepest 
slopes. Conversely, healthy subjects exhibit the least steep slopes, especially with respect to the 
upward expiratory slope (S E 2). 
 
 
 
  
Fig. 3 Signals of a CHF patient with PB: (a) The respiratory flow signal and (b) related templates 
calculated in the four windows indicated in (a). The following trends, resulting from sliding window 
analysis, are displayed: (c) duration of inspiration (D I ) and expiration (D E ), (d) maximal inspiratory 
(M I ) and expiratory (M E ) flow value, (c) downward inspiratory (S I 2 ) and expiratory (S E 2 ) slope, 
and (f) upward inspiratory (S I 1 ) and expiratory (S E 2 ) slope.  
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Fig. 4 Signals of a CHF patient with nPB; see Fig. 3 for an explanation of (a)-(f).  
 
 
Fig. 5 Signals of a healthy subject see Fig. 3 for an explanation of (a)-(f).  
 
 
 
Fig. 6 Schematic representation of different slopes of the respiratory flow template cycle and their 
mean values. 
 
3.2. Performance of the time domain parameters 
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Table 4 presents median, interquartile range, and p-value of the most statistically signiﬁcant 
parameters when analyzing 15-min signals. The parameters corresponding to mean and standard 
deviation of characteristics are shown in Table 1. 
 
Table 4 Median and interquartile range of the most statistically significant parameters of the 
respiratory template cycle when comparing CHF patients, PB and nPB patients, and healthy subjects  
 CHF PB nPB Healthy p-value 
CHF vs. H 
p-value 
PB vs. nPB 
p-value 
nPB vs. H 
M_DI 1.20 (0.30) 1.11 (0.28) 1.23 (0.30) 1.5 (0.36) 0.0002 n.s. 0.005 
M_DE 2.04 (0.45) 1.74 (0.41) 2.12 (0.45) 2.56 (1.27) 0.0003 0.016 0.009 
M_I E 0.54 (0.12) 0.54 (0.11) 0.54 (0.11) 0.87 (0.35) 0.0004 n.s. 0.0003 
M_S I2 -0.68 (0.41) -0.83 (0.33) -0.66 (0.27) -0.36 (0.22) 0.0004 0.041 0.004 
M_S E1 0.59 (0.37) 0.78 (0.23) 0.48 (0.35) 0.21 (0.16) 0.0005 0.009 0.0002 
SD_DI 0.18 (0.07) 0.18 (0.04) 0.19 (0.07) 0.33 (0.22) 0.0004 n.s. 0.0005 
SD_DE 0.27 (0.15) 0.21 (0.09) 0.30 (0.20) 0.47 (0.46) 0.0002 n.s. 0.008 
SD_I E 0.10 (0.04) 0.10 (0.02) 0.09 (0.05) 0.21 (0.15) 0.0003 n.s. 0.0005 
SD_S I2 -0.28 (0.23) -0.31 (0.22) -0.27 (0.24) -0.11 (0.11) 0.0005 0.026 0.006 
SD_S E1 -0.16 (0.16) -0.26 (0.18) -0.14 (0.11) -0.08 (0.06) 0.0004 0.035 0.004 
SD_S E2 0.06 (0.06) 0.11 (0.04) 0.05 (0.03) 0.04 (0.02) 0.02 0.001 n.s. 
M XX : Mean value of each parameter, of each patient, during 15 min of signal; SD XX : Standard 
deviation of each parameter; n.s.: not significant (p-value > 0.05) 
 
 
PB vs nPB: The mean value of DE is lower in PB than in nPB patients (p = 0.009). All slopes (SI1, 
SI2, SE1, and SE2) are steeper in PB patients than in nPB patients. 
CHF patients vs healthy subjects: The mean values of DI and DE are lower in CHF patients than in 
healthy subjects. The maximal expiratory ﬂow interval IE is shorter and with a lower dispersion in 
CHF patients than in healthy subjects. CHF patients present much steeper slopes (SI2 and SE1) with a 
higher dispersion when compared to healthy subjects. All parameters are signiﬁcantly diﬀerent with 
a p < 0.0005, except the standard deviation of SE2 with p = 0.02. 
nPB patients vs healthy subjects: The results show that IE is shorter and with a lower dispersion in 
nPB patients than in healthy subjects (both p < 0.0005). Furthermore, it is shown that SI2 (p = 0.004) 
and SE1 (p < 0.0005) are steeper and with higher dispersion in nPB patients. 
 
3.3. Performance using different signal lengths 
The performance of the most discriminatory parameters (p < 0.01) is studied with respect to signal 
length, for ranges from 1 to 5 min, being SD_SE2 and SD_IE in time domain and R and  ?̅?  in the 
correntropy spectral domain. The accuracy, sensitivity, and speciﬁcity of these parameters are 
presented in Table 5 for 1-min signals (the minimal signal length used to calculate CSD values). 
When classifying PB vs nPB patients, the standard deviation of the upward expiratory slope (SD_SE2) 
has an accuracy of 82%, and R an accuracy of 78%. When comparing CHF patients vs healthy 
subjects, SD_IE has an accuracy of 89%, whereas  ?̅?  has an accuracy of 85%. When classifying nPB 
patients and healthy subjects, the mean of the maximal expiratory ﬂow interval (M _IE ) correctly 
identiﬁes the 91% of the subjects, and  ?̅?  the 89%. 
 
Table 5 Accuracy (Acc), Sensitivity (SE ) and Specificity (Sp) obtained with the best parameter for 
each classification of 1-min signal length 
Classification  Parameter Acc SE Sp 
Morphology parameters 
PB vs. nPB  SD_SE2 82% 75% 94% 
CHF vs. H SD_IE 89% 85% 91% 
nPB vs. H M_IE 91% 84% 91% 
CSD parameters 
PB vs. nPB  R 78% 88% 74% 
CHF vs. H ?̅? 85% 100% 74% 
nPB vs. H ?̅? 89% 100% 68% 
 
 The accuracy of the most discriminatory parameters is evaluated for diﬀerent signal lengths, see 
Figure 7. These results show that the time domain parameters perform slightly better than the CSD-
based parameters for signals shorter than 1.5- min. This diﬀerence is maintained for 5-min signals 
when classifying PB vs nPB patients with an accuracy of 96% (SD_SE2) vs. 93% (R). The CSD-based 
parameters perform slightly better than the time domain parameters for most signal lengths, when 
comparing CHF patients vs. healthy subjects, and nPB patients vs. healthy subjects. In these cases, 
the accuracies obtained with 5-min signals are 97% (?̅? ) vs 94% (SD_IE ) in the ﬁrst case, and 98% 
(?̅? ) vs 94% (M _IE ) in the second case. 
 
 
Fig. 7 Accuracy as a function of signal length, using the best parameters (see Table 5), when 
classifying (a) PB vs. nPB patients, (b) CHF patients vs. healthy subjects, and (c) nPB patients vs. 
healthy subjects. 
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4. Discussion  
In this study, we have proposed a number of time domain parameters to characterize the respiratory 
ﬂow cycle morphology in CHF patients, a method that is advantageous as it provides clinically 
relevant information even when only short-length signals are available. We have successfully used 
respiratory ﬂow cycle morphology to detect PB in CHF patients, information which represents a 
strong predictor of poor prognosis. A respiratory template cycle is calculated for every 30-s 
respiratory ﬂow signal segment. The time domain parameters, extracted from the template, provide 
statistically signiﬁcant diﬀerences when comparing CHF patients (PB and nPB) and healthy subjects. 
 
Selecting the length of the sliding window was a trade-oﬀ between providing a reliable respiratory 
ﬂow cycle template and the capability to track changes in the respiratory cycle morphology during 
PB. Longer windows provide larger ensemble sizes and permit the estimation of a more reliable 
respiratory ﬂow cycle template. On the other hand, shorter window lengths provide better monitoring 
of changes in the respiratory cycle morphology. A sliding window of 30 s (80% overlap) moving 
forward in steps of 6 s allowed us to extract a robust cycle template (with ensemble sizes ranging 
from 4-30 cycles) and monitor changes in its morphology over the PB period (ranging from 25-100 
s). 
 
The highest diﬀerence in the morphology of the respiratory ﬂow cycle, among the diﬀerent breathing 
patterns, is presented in the expiration through the upward expiratory slope and the maximal 
expiratory ﬂow. The estimated maximal expiratory ﬂow interval is shorter and with a lower 
dispersion in CHF patients than in healthy subjects. CHF patients and foremost PB patients present 
a more compressed respiratory cycle. They show steeper slopes and lower inspiratory and expiratory 
times than healthy subjects. When classifying PB and nPB patients, all the slopes are steeper, and 
the standard deviation of the maximal inspiratory and expiratory ﬂow value is much higher in PB 
than in nPB patients. This could be related to the periodicity of the respiratory pattern. 
Periodic breathing pattern, frequently observed in patients with chronic heart failure, has been 
associated with increased risk of mortality. This pattern has been analyzed, mostly in relation with 
the sleep disorders [23], [35]; in healthy subjects, analyzing the relationship between the blood 
pressure and heart rate oscillations, through the tidal volume [19], and in the acclimatization to high 
altitude in healthy mountaineers [6], [24]. Despite advances in treatments of cardiovascular disease, 
the incidence and prevalence of heart failure continues to increase, which can be directly related to 
an increase in life span. In clinical practice, the CHF patients evolution is treated assessing indicators 
such as New York Heart Association (NYHA) classiﬁcation, the percentage left ventricular ejection 
fraction (LVEF), and the level of natriuretic peptide (NT-proBNP) [2]. CHF patients normally have 
higher NYHA and ProBNP values, and lower LVEF percentages. Their diagnosis is based on tests 
whose results sometimes takes several days.  
 
Introducing additional and more immediate information about the condition of the patient through 
the analysis of respiratory cycle morphology is expected to sup- port clinical decision and to prompt 
earlier treatment. The respiratory ﬂow signal is commonly recorded in patients with cardiac and 
respiratory diseases, facilitating the implementation of the proposed analysis in clinical practice. 
CHF patients are regularly assessed in clinical practice and their treatment is adjusted based on their 
condition. Changes in the respiratory ﬂow cycle morphology can indicate decompensation or poor 
prognosis for these patients, which can be useful to monitor and adjust their treatment. 
 
In our previous studies, we characterized the respiratory pattern of CHF patients in the spectral 
domain using either the envelope of the respiratory ﬂow signal [9], or the correntropy of the 
respiratory ﬂow signal [10]. Correntropy was found to be particularly well-suited to characterize 
diﬀerent breathing patterns in CHF patients and identify patients’ condition. It was tested with 15-
min of respiratory ﬂow signals and provided an accuracy of 88.9% classifying PB vs nPB patients, 
and 95.2% classifying CHF patients vs healthy subjects. 
 
Although CSD-based parameters perform slightly better with longer signals, shorter signals are 
needed for morphologic characterization to get signiﬁcant parame- ters that identify CHF (PB and 
nPB) patients and healthy subjects. According to these results, 1-min signals could provide relevant 
information about patient’s condition (see Fig. 7). Thus, a promising advantage of the present 
morphologic characterization is its capability to provide clinically relevant information even from 
short-length respiratory ﬂow signals, which are much easier to acquire in clinical practice. 
A better risk assessment, which includes breathing patterns in heart failure, is clinically of great value 
as it more accurately identiﬁes patients with CHF at increased risk of re-hospitalization and/or death 
who could then be targeted for more intensive monitoring and personalized treatment. Moreover, the 
characterization of the respiratory cycle morphology provides information that is easily interpretable 
by clinicians, which facilitates its introduction in clinical practice. 
Limitations and Future Research: A study limitation is that the proposed method was developed and 
tested with leave-one-out crossvalidation using the same dataset. Thus, further validation of the 
method on a larger dataset is needed before it can be considered for clinical adoption. Despite the 
promising results obtained with simple statistical measures (median and interquartile range) of the 
morphologic parameters, it is of interest to pursue trend analysis and/or individual waveform analysis 
in future studies. Another limitation of this study is that age is not matched between CHF patients 
and healthy subjects. However, it has been reported that the respiratory rate does exhibit signiﬁcant 
diﬀerences with respect to age [33], [22]. 
 
 
5. Conclusions 
Based on a respiratory template cycle, obtained with a novel time alignment method, various 
parameters such as inspiratory and expiratory durations, maximal expiratory ﬂow interval and slopes 
are found to oﬀer good discrimination between respiratory patterns in CHF patients (PB and nPB) 
and healthy subjects. Maximal expiratory ﬂow interval occurs earlier with higher slopes, and reduced 
inspiratory and expiratory duration, in CHF patients and foremost in PB patients than in healthy 
subjects. The results suggest that the analysis of the respiratory ﬂow cycle morphology is a promising 
approach to study respiratory patterns and provide clinically relevant and interpretable information 
about CHF patients’ condition, especially when dealing with short length signals. 
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